Elyse Lower, MD, discusses the importance of tucatinib in the treatment of patients with HER2-positive breast cancer.
Elyse Lower, MD
Advertisement
Articles by Elyse Lower, MD
Elyse Lower, MD, discusses the impact of tucatinib on the treatment of patients with HER2-positive breast cancer.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC
2
PRAME-Directed Therapies Advance Melanoma Treatment Across Clinical Settings
3
META 10-19 Elicits High Complete Response Rate at Ultra-Low Doses in High-Risk R/R DLBCL
4
CD33-Directed CAR T-Cell Therapies Elicit Complete Remissions in Relapsed/Refractory AML
5